These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15880065)

  • 1. Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices.
    Gonzalez-Stawinski GV; Cook DJ; Chang AS; Atik F; Navia JL; Banbury M; Roselli E; Young JB; Starling RA; Smedira NG
    Transplantation; 2005 May; 79(9):1175-9. PubMed ID: 15880065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
    Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
    J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
    Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
    J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.
    Baran DA; Gass AL; Galin ID; Zucker MJ; Arroyo LH; Goldstein DJ; Prendergast T; Lubitz S; Courtney MC; Correa R; Chan M; Spielvogel D; Lansman SL
    J Heart Lung Transplant; 2005 Nov; 24(11):1886-90. PubMed ID: 16297796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
    Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
    J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.
    Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ
    Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab.
    Lick SD; Beckles DL; Piovesana G; Vaidya S; Indrikovs A; Barbagelata NA; Valentine V
    Ann Thorac Surg; 2011 Oct; 92(4):1428-34. PubMed ID: 21855854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.
    See SB; Clerkin KJ; Kennel PJ; Zhang F; Weber MP; Rogers KJ; Chatterjee D; Vasilescu ER; Vlad G; Naka Y; Restaino SW; Farr MA; Topkara VK; Colombo PC; Mancini DM; Schulze PC; Levin B; Zorn E
    J Heart Lung Transplant; 2017 Aug; 36(8):862-870. PubMed ID: 28431981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant Outcomes for Congenital Heart Disease Patients Bridged With a Ventricular Assist Device.
    Bryant R; Rizwan R; Villa CR; Zafar F; Wells D; Chin C; Lorts A; Morales DL
    Ann Thorac Surg; 2018 Aug; 106(2):588-594. PubMed ID: 29723531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitisation and post-transplant course after the implantation of ventricular assist device.
    Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of allosensitized cardiac transplant candidates.
    Velez M; Johnson MR
    Transplant Rev (Orlando); 2009 Oct; 23(4):235-47. PubMed ID: 19778695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular assist device bridging with gender-mismatch increases rejection and decreases survival following a heart transplant.
    Itoda Y; Okamoto T; Niikawa H; Ayyat KS; Tu C; McCurry KR
    Eur J Cardiothorac Surg; 2021 Jan; 59(1):217-225. PubMed ID: 33057607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.
    Sharples LD; Jackson CH; Parameshwar J; Wallwork J; Large SR
    Transplantation; 2003 Aug; 76(4):679-82. PubMed ID: 12973108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosensitization does not alter post-transplant outcomes in pediatric patients bridged to transplant with a ventricular assist device.
    Castleberry C; Zafar F; Thomas T; Khan MS; Bryant R; Chin C; Morales DL; Lorts A
    Pediatr Transplant; 2016 Jun; 20(4):559-64. PubMed ID: 27102953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
    Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
    Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis.
    Topkara VK; O'Neill JK; Carlisle A; Novak E; Silvestry SC; Ewald GA
    Ann Thorac Surg; 2014 Feb; 97(2):506-12. PubMed ID: 24140211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.